Article History
Received: 8 September 2022
Accepted: 5 November 2022
First Online: 28 November 2022
Declarations
:
: The authors have no competing financial interests.
: This prospective, randomized controlled trial was conducted in accordance with the Declaration of Helsinki. The study was approved by the institutional review board of Seoul National University Bundang Hospital, Gyeonggi-do, Korea (B-2009–634-004). The clinical trial was registered at the Clinical Research Information Service (KCT0005631).
: Written informed consent was obtained from all patients to participate in this study.